# Allarity Therapeutics, Inc.: Form 8-K, filed Dec 23, 2025

- Company: [Allarity Therapeutics, Inc.](/companies/allr.md) (CIK 1860657)
- Form: 8-K
- Filed: 2025-12-23
- Accepted by EDGAR: Dec 23, 2025, 09:21 ET
- Period: 2025-12-23
- Accession: 0001213900-25-124935
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1860657/000121390025124935/ea0270724-8k_allarity.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1860657/000121390025124935/

## Items reported

- Item 3.02: Unregistered sale of equity

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1860657/000121390025124935/ea0270724-8k_allarity.htm

Filed Dec 23, 2025.
Source: SEC EDGAR, the filing index for accession 0001213900-25-124935. Last ingested by Listed: Nov 2, 2026, 08:01 ET. No prices; not investment advice.
